Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1987
Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vectorR I Garver, A Chytil, S Karlsson, et al.
Human Gene Therapy|February 15, 2001
Systemic administration of a matrix-targeted retroviral vector is efficacious for cancer gene therapy in miceE M Gordon, Z H Chen, L Liu, et al.
Annals of Surgery|October 1, 1993
The development of gene therapy for the treatment of cancerS A Rosenberg, W F Anderson, M Blaese, et al.
Lancet (London, England)|November 6, 1993
Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patientsM K Brenner, D R Rill, M S Holladay, et al.
Human Gene Therapy|July 10, 1996
Retroviral gene transfer in autologous bone marrow transplantation for adult acute leukemiaK Cornetta, E F Srour, A Moore, et al.
Blood|July 1, 1991
Expression of a foreign gene in cats reconstituted with retroviral vector infected autologous bone marrowC D Lothrop, Z S al-Lebban, G P Niemeyer, et al.
Human Gene Therapy|June 2, 1998
Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapyD R LeMay, M Kittaka, E M Gordon, et al.
British Journal of Cancer|June 7, 2006
Established breast cancer risk factors by clinically important tumour characteristicsM García-Closas, L A Brinton, J Lissowska, et al.
Breast Cancer Research and Treatment|February 8, 2008
Human epidermal growth factor receptor-2 and estrogen receptor expression, a demonstration project using the residual tissue repository of the Surveillance, Epidemiology, and End Results (SEER) programW F Anderson, S Luo, N Chatterjee, et al.
Science (New York, N.Y.)|October 20, 1995
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 yearsR M Blaese, K W Culver, A D Miller, et al.
Pageof 30